Determination of genetic predisposition to patent ductus arteriosus in preterm infants

Pediatrics

Volumn 123, Issue 4, 2009, Pages 1116-1123

  Dagle, John M ^a,c   Lepp, Nathan T ^a   Cooper, Margaret E ^b   Schaa, Kendra L ^a   Kelsey, Keegan J P ^a   Orr, Kristin L ^a   Caprau, Diana ^a   Zimmerman, Cara R ^a   Steffen, Katherine M ^a   Johnson, Karen J ^a   Marazita, Mary L ^b   Murray, Jeffrey C ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c 8805 JPP ^*  (United States)

Author keywords

Genetic predisposition; Patent ductus arteriosus; Premature infants

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; DNA; INDOMETACIN; PROSTACYCLIN SYNTHASE; TRANSCRIPTION FACTOR AP 2; TUMOR NECROSIS FACTOR RECEPTOR; XENOBIOTIC AGENT; ANGIOTENSIN 1 RECEPTOR; CETP PROTEIN, HUMAN; CHOLESTEROL ESTER TRANSFER PROTEIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CRF RECEPTOR TYPE 1; CYTOCHROME P450; CYTOCHROME P450 2D6; ISOMERASE; TFAP2B PROTEIN, HUMAN; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ARTICLE; DETOXIFICATION; FEMALE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GESTATIONAL AGE; HAPLOTYPE; HUMAN; INFANT; INFLAMMATION; MALE; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE CONTRACTION; GENETICS; NEWBORN;

CHOLESTEROL ESTER TRANSFER PROTEINS; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; DUCTUS ARTERIOSUS, PATENT; GENETIC PREDISPOSITION TO DISEASE; GESTATIONAL AGE; HAPLOTYPES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTRAMOLECULAR OXIDOREDUCTASES; LIPASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; TNF RECEPTOR-ASSOCIATED FACTOR 1; TRANSCRIPTION FACTOR AP-2;

EID: 65349163518     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-0313     Document Type: Article

References (30)

1. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol. 2006;26(suppl 1):S14-S18
2. Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate. 2006;89(4):330-335 (Pubitemid 43886949)
3. Lemmers PM, Toet MC, van Bel F. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants. Pediatrics. 2008;121(1):142-147
4. Horbar JD. The Vermont-Oxford Neonatal Network: integrating research and clinical practice to improve the quality of medical care. Semin Perinatol. 1995;19(2):124-131
5. Satoda M, Pierpont ME, Diaz GA, Bornemeier RA, Gelb BD. Char syndrome, an inherited disorder with patent ductus arteriosus, maps to chromosome 6p12-p21. Circulation. 1999;99(23):3036-3042 (Pubitemid 29270434)
6. Mani A, Meraji SM, Houshyar R, et al. Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus. Proc Natl Acad Sci U S A. 2002;99(23):15054-15059 (Pubitemid 35334608)
7. Mani A, Radhakrishnan J, Farhi A, et al. Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder. Proc Natl Acad Sci U S A. 2005;102(8):2975-2979 (Pubitemid 40299901)
8. Zhu L, Vranckx R, Khau Van Kien P, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet. 2006;38(3):343-349 (Pubitemid 43315758)
9. Treszl A, Szabo M, Dunai G, et al. Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates. Pediatr Res. 2003;54(5):753-755 (Pubitemid 37310778)
10. Ehn NL, Cooper ME, Orr K, et al. Evaluation of fetal and maternal genetic variation in the progesterone receptor gene for contributions to preterm birth. Pediatr Res. 2007;62(5):630-635
11. Steffen KM, Cooper ME, Shi M, et al. Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery. J Perinatol. 2007;27(11):672-680 (Pubitemid 350020346)
12. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998;63(1):259-266 (Pubitemid 30428342)
13. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet. 2001;9(4):301-306 (Pubitemid 32366699)
14. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol. 2000;19(suppl 1):S36-S42
15. Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered. 2000;50(4):211-223 (Pubitemid 30232624)
16. Bhandari V, Bizzarro MJ, Shetty A, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics. 2006;117(6):1901-1906 (Pubitemid 46071232)
17. Bizzarro MJ, Hussain N, Jonsson B, et al. Genetic susceptibility to retinopathy of prematurity. Pediatrics. 2006;118(5):1858-1863 (Pubitemid 46393666)
18. Christensen K, Murray JC. What genome-wide association studies can do for medicine. N Engl J Med. 2007;356(11):1094-1097
19. Hilger-Eversheim K, Moser M, Schorle H, Buettner R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene. 2000;260(1-2):1-12 (Pubitemid 32008495)
20. Moser M, Pscherer A, Roth C, et al. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. Genes Dev. 1997;11(15):1938-1948 (Pubitemid 27332981)
21. Waldo KL, Kirby ML. Cardiac neural crest contribution to the pulmonary artery and sixth aortic arch artery complex in chick embryos aged 6 to 18 days. Anat Rec. 1993;237(3):385-399 (Pubitemid 23320118)
22. Zhang B, Wang Z, Li T, Tsitsikov EN, Ding HF. NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis. Blood. 2007;110(2):743-751
23. Oyoshi MK, Barthel R, Tsitsikov EN. TRAF1 regulates recruitment of lymphocytes and, to a lesser extent, neutrophils, myeloid dendritic cells and monocytes to the lung airways following lipopolysaccharide inhalation. Immunology. 2007;120(3):303-314 (Pubitemid 46232905)
24. Wang S, Robertson GP, Zhu J. A novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancers. Gene. 2004;343(1):69-78 (Pubitemid 39551030)
25. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114(17):1873-1882 (Pubitemid 44673363)
26. Kluckow M, Evans N, Leslie G, Rowe J. Prostacyclin concentrations and transitional circulation in preterm infants requiring mechanical ventilation. Arch Dis Child Fetal Neonatal Ed. 1999;80(1):F34-F37 (Pubitemid 29129595)
27. Nackley AG, Shabalina SA, Tchivileva IE, et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science. 2006;314(5807):1930-1933 (Pubitemid 46026115)
28. Kalis NN, Pieper C, van der Merwe PL, Nel ED. Factors influencing successful closure with indomethacin of the patent ductus arteriosus in premature infants. Cardiovasc J S Afr. 2001;12(5):268-272
29. Hammerman C, Glaser J, Kaplan M, Schimmel MS, Ferber B, Eidelman AI. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics. 1998;102(5). Available at: www.pediatrics.org/cgi/content/full/102/ 5/e56
30. Schmidt B, Roberts RS, Fanaroff A, et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr. 2006;148(6):730-734 (Pubitemid 43870093)